NCT07198776

Brief Summary

Osteoporotic vertebral compression fractures are a common cause of severe back pain and disability in elderly patients. Percutaneous vertebroplasty (PVP) with polymethylmethacrylate (PMMA) cement is widely used to relieve pain and stabilize the fractured vertebra. However, there is ongoing debate whether unilateral or bilateral vertebroplasty provides better clinical and radiological outcomes. This prospective randomized controlled trial was conducted at the University Medical Center Maribor to compare unilateral versus bilateral PVP performed under local anaesthesia. A total of 196 patients with acute osteoporotic vertebral compression fractures were enrolled and randomly assigned to one of the two groups. The primary outcome measure was pain reduction assessed by Visual Analogue Scale (VAS). Secondary outcomes included functional improvement measured by the Oswestry Disability Index (ODI), procedure duration, fluoroscopy time, injected cement volume, radiological changes (vertebral height, kyphotic angle), and perioperative complications. The results are expected to provide evidence to guide optimal surgical management of osteoporotic vertebral fractures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
196

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 30, 2025

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

3.5 years

First QC Date

September 15, 2025

Last Update Submit

September 21, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in pain intensity (VAS score)

    Pain intensity measured on a Visual Analogue Scale (0-10; higher scores = worse pain).

    From baseline (preoperative) to 6 months post-procedure

  • Oswestry Disability Index (ODI)

    Oswestry Disability Index score, range 0-100%, higher scores = greater disability.

    From baseline to 6 months post-procedure

Secondary Outcomes (6)

  • Operative time

    During procedure

  • Fluoroscopy time

    During procedure

  • Injected cement volume

    During procedure

  • Vertebral height restoration

    From baseline (preoperative) to hospital discharge (postoperative day 1)

  • Kyphotic angle correction

    From baseline (preoperative) to hospital discharge (postoperative day 1)

  • +1 more secondary outcomes

Study Arms (2)

Unilateral Vertebroplasty

EXPERIMENTAL

Patients undergo percutaneous unilateral vertebroplasty with polymethylmethacrylate (PMMA) cement under local anaesthesia.

Procedure: Percutaneous Vertebroplasty

Bilateral Vertebroplasty

ACTIVE COMPARATOR

Patients undergo percutaneous bilateral vertebroplasty with polymethylmethacrylate (PMMA) cement under local anaesthesia.

Procedure: Percutaneous Vertebroplasty

Interventions

Injection of PMMA cement into fractured vertebra under fluoroscopic guidance.

Bilateral VertebroplastyUnilateral Vertebroplasty

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may not qualify if:

  • Active infection
  • Coagulopathy
  • Burst fracture with retropulsion
  • Neurological deficit
  • Malignancy-related fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Maribor, Department of Traumatology

Maribor, 2000, Slovenia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Surgery, University Medical Center Maribor

Study Record Dates

First Submitted

September 15, 2025

First Posted

September 30, 2025

Study Start

January 1, 2022

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations